ExodusPoint Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$194K	Buy	+15,137	New	+$193K	﹤0.01%	1385
2025 Q3	–	Sell	-58,609	Closed	-$550K	–	1889
2025 Q2	$550K	Sell	58,609 -29,043	-33%	-$238K	0.01%	1128
2025 Q1	$623K	Sell	87,652 -18,175	-17%	-$184K	0.01%	1063
2024 Q4	$1.23M	Buy	105,827 +52,486	+98%	+$819K	0.01%	881
2024 Q3	$1.1M	Buy	+53,341	New	+$1.23M	0.01%	947
2024 Q2	–	Sell	-80,752	Closed	-$2.22M	–	1857
2024 Q1	$2.22M	Buy	80,752 +13,500	+20%	+$375K	0.03%	659
2023 Q4	$2.05M	Buy	67,252 +35,816	+114%	+$1.03M	0.03%	567
2023 Q3	$994K	Buy	31,436 +24,178	+333%	+$938K	0.01%	971
2023 Q2	$296K	Buy	+7,258	New	+$294K	﹤0.01%	1549
2023 Q1	–	Sell	-9,982	Closed	-$348K	–	2023
2022 Q4	$348K	Sell	9,982 -7,204	-42%	-$343K	0.01%	1304
2022 Q3	$962K	Buy	17,186 +9,283	+117%	+$576K	0.01%	1122
2022 Q2	$409K	Sell	7,903 -9,340	-54%	-$474K	0.01%	1432
2022 Q1	$1.25M	Buy	+17,243	New	+$1.46M	0.02%	1019
2021 Q4	–	Sell	-3,467	Closed	-$465K	–	2471
2021 Q3	$465K	Buy	+3,467	New	+$525K	0.01%	1438
2021 Q1	–	Sell	-9,134	Closed	-$497K	–	2463
2020 Q4	$497K	Sell	9,134 -45,589	-83%	-$1.66M	0.01%	1257
2020 Q3	$1.09M	Buy	54,723 +15,841	+41%	+$330K	0.03%	648
2020 Q2	$817K	Buy	+38,882	New	+$661K	0.02%	844
2019 Q4	–	Sell	-13,089	Closed	-$175K	–	1784
2019 Q3	$175K	Buy	+13,089	New	+$209K	0.01%	1158